Patents Assigned to Cardiff Scintigraphics Limited
  • Patent number: 11260185
    Abstract: The disclosure relates to a pressurized Metered Dose Inhaler-compatible tablet, i.e. one that is able to be dispersed or disintegrates within a liquid phase propellant, which is used in a pressurized Metered Dose Inhaler formulation containing at least one active pharmaceutical ingredient and one or more excipients.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: March 1, 2022
    Assignee: Cardiff Scintigraphics Limited
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Patent number: 9981092
    Abstract: The invention relates to a method for the manufacture of a pressurized Metered Dose Inhaler (pMDI) and components for use in said method, in particular, a pMDI compatible tablet (i.e. one that is able to be dispersed or disintegrates within a liquid phase, such as a propellant, used in a pMDI formulation) which contains at least one active pharmaceutical ingredient (API) and, optionally, one or more excipients.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: May 29, 2018
    Assignee: CARDIFF SCINTIGRAPHICS LIMITED
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Patent number: 6737044
    Abstract: An aerosol composition comprising a propellant and a first particulate material comprising particle having a median aerodynamic diameter within the range 0.05 to 11 &mgr;m, such as a medicament suitable for pulmonary inhalation, and a second particulate material comprising particles having a median volume diameter within the range 15 to 200 &mgr;m. The presence of the second particulate material provides good suspension properties, particularly where the propellant is a hydrofluoro alkane.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: May 18, 2004
    Assignees: University College Cardiff Consultants Limited, Cardiff Scintigraphics Limited
    Inventors: Paul Alfred Dickinson, Simon John Warren